Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carragher

Showing results (481-490 of 508) with videos related to

Pageof 51
Sort By:
Molecular Systems Biology|March 28, 2026
Progress and new challenges in image-based profilingErik Serrano, John Peters, Jesko Wagner, et al.
The Journal of Experimental Medicine|February 7, 2023
Macrophages promote anti-androgen resistance in prostate cancer bone diseaseXue-Feng Li, Cigdem Selli, Han-Lin Zhou, et al.
Cancer Research|December 5, 2024
Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in MelanomaCatriona A Ford, Dana Koludrovic, Patricia P Centeno, et al.
Nature Communications|May 2, 2022
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapiesJamie I Scott, Lorena Mendive-Tapia, Doireann Gordon, et al.
Cancer Research|August 21, 2021
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and TolerabilityCarolin Temps, Daniel Lietha, Emily R Webb, et al.
Molecular Psychiatry|November 8, 2018
Reversal of proliferation deficits caused by chromosome 16p13.11 microduplication through targeting NFκB signaling: an integrated study of patient-derived neuronal precursor cells, cerebral organoids and in vivo brain imagingMandy Johnstone, Navneet A Vasistha, Miruna C Barbu, et al.
Journal of Structural Biology|November 7, 2022
Smart data collection for CryoEMTristan Bepler, Andrew J Borst, Jonathan Bouvette, et al.
Cancer Cell|December 16, 2014
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanomaMaria Romina Girotti, Filipa Lopes, Natasha Preece, et al.
Nature Communications|October 18, 2017
TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3pJonathan Berrout, Eleni Kyriakopoulou, Lavanya Moparthi, et al.
Journal of Structural Biology|August 23, 2017
Best practices for managing large CryoEM facilitiesBart Alewijnse, Alun W Ashton, Melissa G Chambers, et al.
Pageof 51

Showing results (481-490 of 508) with videos related to

Sort By:
Pageof 51
Molecular Systems Biology|March 28, 2026
Progress and new challenges in image-based profilingErik Serrano, John Peters, Jesko Wagner, et al.
The Journal of Experimental Medicine|February 7, 2023
Macrophages promote anti-androgen resistance in prostate cancer bone diseaseXue-Feng Li, Cigdem Selli, Han-Lin Zhou, et al.
Cancer Research|December 5, 2024
Targeting the PREX2/RAC1/PI3Kβ Signaling Axis Confers Sensitivity to Clinically Relevant Therapeutic Approaches in MelanomaCatriona A Ford, Dana Koludrovic, Patricia P Centeno, et al.
Nature Communications|May 2, 2022
A fluorogenic probe for granzyme B enables in-biopsy evaluation and screening of response to anticancer immunotherapiesJamie I Scott, Lorena Mendive-Tapia, Doireann Gordon, et al.
Cancer Research|August 21, 2021
A Conformation Selective Mode of Inhibiting SRC Improves Drug Efficacy and TolerabilityCarolin Temps, Daniel Lietha, Emily R Webb, et al.
Molecular Psychiatry|November 8, 2018
Reversal of proliferation deficits caused by chromosome 16p13.11 microduplication through targeting NFκB signaling: an integrated study of patient-derived neuronal precursor cells, cerebral organoids and in vivo brain imagingMandy Johnstone, Navneet A Vasistha, Miruna C Barbu, et al.
Journal of Structural Biology|November 7, 2022
Smart data collection for CryoEMTristan Bepler, Andrew J Borst, Jonathan Bouvette, et al.
Cancer Cell|December 16, 2014
Paradox-breaking RAF inhibitors that also target SRC are effective in drug-resistant BRAF mutant melanomaMaria Romina Girotti, Filipa Lopes, Natasha Preece, et al.
Nature Communications|October 18, 2017
TRPA1-FGFR2 binding event is a regulatory oncogenic driver modulated by miRNA-142-3pJonathan Berrout, Eleni Kyriakopoulou, Lavanya Moparthi, et al.
Journal of Structural Biology|August 23, 2017
Best practices for managing large CryoEM facilitiesBart Alewijnse, Alun W Ashton, Melissa G Chambers, et al.
Pageof 51